[PMID]: | 28137973 |
[Au] Autor: | Howarth C; Sutherland B; Choi HB; Martin C; Lind BL; Khennouf L; LeDue JM; Pakan JM; Ko RW; Ellis-Davies G; Lauritzen M; Sibson NR; Buchan AM; MacVicar BA |
[Ad] Endereço: | Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada. |
[Ti] Título: | A Critical Role for Astrocytes in Hypercapnic Vasodilation in Brain. |
[So] Source: | J Neurosci;37(9):2403-2414, 2017 Mar 01. |
[Is] ISSN: | 1529-2401 |
[Cp] País de publicação: | United States |
[La] Idioma: | eng |
[Ab] Resumo: | Cerebral blood flow (CBF) is controlled by arterial blood pressure, arterial CO , arterial O , and brain activity and is largely constant in the awake state. Although small changes in arterial CO are particularly potent to change CBF (1 mmHg variation in arterial CO changes CBF by 3%-4%), the coupling mechanism is incompletely understood. We tested the hypothesis that astrocytic prostaglandin E (PgE ) plays a key role for cerebrovascular CO reactivity, and that preserved synthesis of glutathione is essential for the full development of this response. We combined two-photon imaging microscopy in brain slices with work in rats and C57BL/6J mice to examine the hemodynamic responses to CO and somatosensory stimulation before and after inhibition of astrocytic glutathione and PgE synthesis. We demonstrate that hypercapnia (increased CO ) evokes an increase in astrocyte [Ca ] and stimulates COX-1 activity. The enzyme downstream of COX-1 that synthesizes PgE (microsomal prostaglandin E synthase-1) depends critically for its vasodilator activity on the level of glutathione in the brain. We show that, when glutathione levels are reduced, astrocyte calcium-evoked release of PgE is decreased and vasodilation triggered by increased astrocyte [Ca ] and by hypercapnia is inhibited. Astrocyte synthetic pathways, dependent on glutathione, are involved in cerebrovascular reactivity to CO Reductions in glutathione levels in aging, stroke, or schizophrenia could lead to dysfunctional regulation of CBF and subsequent neuronal damage. Neuronal activity leads to the generation of CO , which has previously been shown to evoke cerebral blood flow (CBF) increases via the release of the vasodilator PgE We demonstrate that hypercapnia (increased CO ) evokes increases in astrocyte calcium signaling, which in turn stimulates COX-1 activity and generates downstream PgE production. We demonstrate that astrocyte calcium-evoked production of the vasodilator PgE is critically dependent on brain levels of the antioxidant glutathione. These data suggest a novel role for astrocytes in the regulation of CO -evoked CBF responses. Furthermore, these results suggest that depleted glutathione levels, which occur in aging and stroke, will give rise to dysfunctional CBF regulation and may result in subsequent neuronal damage. |
[Mh] Termos MeSH primário: |
Astrócitos/metabolismo Hipocampo/patologia Hipercapnia/patologia
|
[Mh] Termos MeSH secundário: |
Agonistas de Receptores Adrenérgicos alfa 2/farmacologia Agonistas alfa-Adrenérgicos/farmacologia Animais Animais Recém-Nascidos Dióxido de Carbono/metabolismo Dióxido de Carbono/farmacologia Circulação Cerebrovascular/efeitos dos fármacos Clonidina/farmacologia Cicloleucina/análogos & derivados Cicloleucina/farmacologia Ciclo-Oxigenase 1/metabolismo Dinoprostona/metabolismo Feminino Proteína Glial Fibrilar Ácida/metabolismo Glutationa/metabolismo Técnicas In Vitro Masculino Proteínas de Membrana/metabolismo Camundongos Camundongos Endogâmicos C57BL Fármacos Neuroprotetores/farmacologia Norepinefrina/farmacologia Ratos Ratos Wistar Vibrissas/inervação
|
[Pt] Tipo de publicação: | JOURNAL ARTICLE |
[Nm] Nome de substância:
| 0 (Adrenergic alpha-2 Receptor Agonists); 0 (Adrenergic alpha-Agonists); 0 (Glial Fibrillary Acidic Protein); 0 (Membrane Proteins); 0 (Neuroprotective Agents); 0TQU7668EI (Cycloleucine); 111900-32-4 (1-amino-1,3-dicarboxycyclopentane); 142M471B3J (Carbon Dioxide); EC 1.14.99.1 (Cyclooxygenase 1); EC 1.14.99.1 (Ptgs1 protein, mouse); GAN16C9B8O (Glutathione); K7Q1JQR04M (Dinoprostone); MN3L5RMN02 (Clonidine); X4W3ENH1CV (Norepinephrine) |
[Em] Mês de entrada: | 1708 |
[Cu] Atualização por classe: | 170818 |
[Lr] Data última revisão:
| 170818 |
[Sb] Subgrupo de revista: | IM |
[Da] Data de entrada para processamento: | 170201 |
[St] Status: | MEDLINE |
[do] DOI: | 10.1523/JNEUROSCI.0005-16.2016 |
|
|